Mitoxantrone Completed Phase 2 Trials for Relapsing Remitting Multiple Sclerosis (RRMS) Diagnostic

IndicationsStatusPurposePhase
CompletedDiagnostic2
clinicaltrials.gov IdentifierTitleDrugs
NCT00203073A Study to Evaluate the Safety and Effectiveness of Novantrone Therapy Followed by Copaxone for Multiple Sclerosis.